From: The predictive value of creatinine clearance for mortality in patients undergoing revascularization
eGFR ≤60 (N = 126) | Discordant eGFR (N = 203) | eGFR > 60 (N = 783) | p-value | |
---|---|---|---|---|
Age (years) (mean ± SD) | 74 ± 10 | 73 ± 9 | 62 ± 10 | < 0.001 |
Gender (male) (%) | 86 (68) | 136 (67) | 663 (85) | < 0.001 |
Hypertension (%) | 119 (94) | 170 (84) | 530 (68) | < 0.001 |
Previous PCI (%) | 45 (36) | 75 (37) | 267 (34) | 0.751 |
COPD (%) | 11 (9) | 20 (10) | 47 (6) | 0.116 |
Diabetes (%) | 82 (65) | 98 (48) | 321 (41) | < 0.001 |
Hemodialysis (%) | 5 (4) | 0 (0) | 0 (0) | < 0.001 |
Hyperlipidemia (%) | 102 (82) | 152 (76) | 562 (73) | 0.087 |
Smoking (%) | 19 (15) | 40 (20) | 236 (30) | < 0.001 |
CHF (%) | 23 (19) | 29 (14) | 64 (8) | < 0.001 |
Prior CVA/TIA (%) | 16 (13) | 36 (18) | 51 (6) | < 0.001 |
Atrial fibrillation (%) | 12 (10) | 24 (12) | 46 (6) | 0.008 |
SYNTAX score (mean ± SD) | 23 ± 9 | 24 ± 11 | 22 ± 10 | 0.026 |
Body mass index (Kg/m2) (mean ± SD) | 28 ± 4.7 | 28.3 ± 7.1 | 28.9 ± 5.1 | 0.138 |
Medical treatment | ||||
Aspirin (%) | 93 (77) | 149 (76) | 519 (70) | 0.121 |
Beta blockers (%) | 82 (66) | 122 (60) | 367 (48) | < 0.001 |
ACE-I (%) | 62 (49) | 97 (48) | 343 (45) | 0.488 |
Statins (%) | 97 (78) | 150 (74) | 514 (67) | 0.012 |
Anti-hyperglycemic (%) | 41 (37) | 62 (34) | 206 (29) | 0.184 |
Laboratory on admission | ||||
Hemoglobin (mean ± SD) | 12 ± 1.7 | 13.1 ± 1.7 | 13.9 ± 1.6 | < 0.001 |
Urea (mean ± SD) | 62.7 ± 49.8 | 32.6 ± 17.3 | 27 ± 13.2 | < 0.001 |
Creatinine (mean ± SD) | 2.57 ± 2.21 | 1.17 ± 0.2 | 0.87 ± 0.19 | < 0.001 |
HbA1C (mean ± SD) | 7.4 ± 2.1 | 6.7 ± 1.6 | 7.1 ± 2 | 0.322 |
Ethnicity | 0.192 | |||
Israeli Jews (%) | 107 (85) | 174 (86) | 613 (78) | |
Israeli Arabs (%) | 19 (15) | 29 (14) | 156 (20) | |
Others (%) | 0 (0) | 0 (0) | 13 (2) |